Search

Search Results

• 

  How to Apply the Canadian Obesity Clinical Practice Guidelines to People with Type 2 Diabetes

  Sue D. Pedersen, MD, FRCPC, DABOM

  5–10

  2023-03-20
• 

  Glucagon-like Peptide-1 Receptor Agonists and Thyroid Cancer: Myth or Reality?

  Ronald M. Goldenberg, MD, FRCPC, FACE

  17–22

  2025-05-08
• 

  Glucagon-like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time?

  Ronald M. Goldenberg, MD, FRCPC, FACE

  5–9

  2026-05-25
• 

  Addressing NAFLD as a Type 2 Diabetes Complication Using the Emerging Paradigms in Diagnostic and Management Techniques

  Harpreet S. Bajaj, MD, MPH, FACE

  26–29

  2023-03-20